Cargando…

Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

BACKGROUND: Esophageal cancers accounted for nearly 16,000 deaths in 2016. The number of patients with esophageal cancers increases every year. Neoadjuvant chemoradiotherapy (nCRT) prior to esophagectomy is a standard treatment for esophageal cancers. The patients who have no residual tumor (patholo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor Ripley, R., Surman, Deborah R., Diggs, Laurence P., Trepel, Jane B., Lee, Min-Jung, Ryan, Jeremy, Davis, Jeremy L., Steinberg, Seth M., Hernandez, Jonathan M., Hoang, Choung, Kenney, Cara M., Bond, Colleen D., Kunst, Tricia F., Letai, Anthony, Schrump, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013848/ https://www.ncbi.nlm.nih.gov/pubmed/29933761 http://dx.doi.org/10.1186/s12876-018-0823-x

Ejemplares similares

Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling
por: Surman, Deborah R., et al.
Publicado: (2021)

Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies
por: Zhang, Mary, et al.
Publicado: (2021)

Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
por: Foight, Glenna Wink, et al.
Publicado: (2014)

BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics
por: Touzeau, Cyrille, et al.
Publicado: (2015)

Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer
por: Potter, Danielle S., et al.
Publicado: (2021)

Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2
por: Xu, Yuan, et al.
Publicado: (2017)

Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
por: Pallis, Monica, et al.
Publicado: (2016)

Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
por: Jenson, Justin M, et al.
Publicado: (2017)

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS(G12R)-mutant pancreatic ductal adenocarcinoma
por: Kenney, Cara, et al.
Publicado: (2021)

Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines
por: Koss, Brian, et al.
Publicado: (2016)

Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma
por: Potter, Danielle S., et al.
Publicado: (2023)

Video-assisted thoracoscopic surgery pleurectomy: a suitable alternative for treating malignant pleural effusions
por: Diggs, Laurence P., et al.
Publicado: (2021)

Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling
por: Rys, Ryan N., et al.
Publicado: (2021)

Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling()
por: Zhang, Li, et al.
Publicado: (2019)

Minority MOMP: a toxic, slow demise
por: Xu, Yuan, et al.
Publicado: (2020)

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases
por: Ripley, Robert T, et al.
Publicado: (2010)

A beam destination read-out for BH3∕BH4
por: Tanke, E
Publicado: (1984)

Interface de controle de BH3 et BH4
por: Liénard, P
Publicado: (1984)

High pressure polymorphism of LiBH(4) and of NaBH(4)
por: Marizy, Adrien, et al.
Publicado: (2021)

Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome
por: Seastedt, Kenneth P., et al.
Publicado: (2021)

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
por: Le Pen, J, et al.
Publicado: (2016)

Boric acid as a precatalyst for BH(3)-catalyzed hydroboration
por: Légaré Lavergne, Julien, et al.
Publicado: (2021)

Technical specification of new coils for the bending magnets BH2 and BH5
Publicado: (1981)

BH3 Peptides Induce Mitochondrial Fission and Cell Death Independent of BAX/BAK
por: Shroff, Emelyn H., et al.
Publicado: (2009)

Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated Perspective
por: Sora, Valentina, et al.
Publicado: (2022)

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
por: Brown, Kate, et al.
Publicado: (2023)

Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
por: Le Pen, J, et al.
Publicado: (2017)

BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia
por: Olesinski, Elyse A., et al.
Publicado: (2023)

BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells
por: Butterworth, Michael, et al.
Publicado: (2016)

Imine Reduction with Me(2)S-BH(3)
por: Kamal, Mohammad M., et al.
Publicado: (2021)

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
por: Davis, Jeremy L, et al.
Publicado: (2011)

Apolipoprotein L2 contains a BH3-like domain but it does not behave as a BH3-only protein
por: Galindo-Moreno, J, et al.
Publicado: (2014)

Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-x(AK)
por: Plötz, Michael, et al.
Publicado: (2012)

Evaluation and Ranking of Researchers – Bh Index
por: Bharathi, D. Gnana
Publicado: (2013)

FIRST BH COCHRANE SYMPOSIUM HELD
por: Mahmic-Kaknjo, Mersiha, et al.
Publicado: (2016)

Mitochondrial apoptosis and BH3 mimetics
por: Dai, Haiming, et al.
Publicado: (2016)

BH(4)-deficient hyperphenylalaninemia in Russia
por: Gundorova, Polina, et al.
Publicado: (2021)

BH3 Mimetics in Hematologic Malignancies
por: Klener, Pavel, et al.
Publicado: (2021)

Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization
por: Dai, Haiming, et al.
Publicado: (2011)

BH3-mimetics: recent developments in cancer therapy
por: Townsend, Paul A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttdll5o84pmvio6m7i9heptggr